Pharmacokietics. Other and unspecified diseases of pulp and periapical tissues
Conditions
Interventions
Intervention 1: Control group: administration placebo one capsule daily for three days. Intervention 2: Alprazolam+Ibuprofen group: administration
Alprazolam+Ibuprofen(0.5mg+400mg) one capsule daily f
Treatment - Drugs
Control group: administration placebo one capsule daily for three days.
Alprazolam+Ibuprofen group: administration
Alprazolam+Ibuprofen(0.5mg+400mg) one capsule daily for three days.
Ibuprofen group: administration
Ibuprofen 400mg one capsule daily for three days.
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: After providing adequate information to the subjects, eligible healthy volunteer will be enrolled in the study. Inclusion criteria: be healthy; normal dite; Non-inhibitor drugs. Exclusion criteria: age below 20 and above 45; smoking; pregnancy; Breastfeeding.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analog scale. Timepoint: 4,6,12,24,48,72 hours after taking the medicine of regular intervals. Method of measurement: Pain by visual assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDR. Ali Akbar Moghadamnia
Babol University of Medical Sciences
Outcome results
None listed